Systemic side effects of Latanoprost therapy in a child with aniridia and glaucoma;Systemische nebenwirkung von Latanoprost bei einem kind mit aniridie und glaukom

Ophthalmologe

Volumn 95, Issue 9, 1998, Pages 633-634

  Schmidtborn, Frank ^a  

^a Augenarzt   (Germany)

Author keywords

Aniridia; Child glaucoma; Glaucoma; Latanoprost

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EYE DROPS; LATANOPROST;

ANIRIDIA; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CASE REPORT; CHILD; GLAUCOMA; HUMAN; SWEAT GLAND DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ANIRIDIA; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GLAUCOMA; HUMANS; MALE; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; SWEATING;

EID: 13144305096     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050326     Document Type: Article

References (2)

1. Alm A (1993) The potential of prostaglandin derivates in glaucoma therapie. Curr Opin Ophthalmol 4: 44-50
2. Diestelhorst M (1997) Glaukomtherapie mit Prostaglandin-F2α-Derivaten. Ophthalmologe 97: 754-769